How do you manage patients with germline BRCA mutations who have STIC lesions found at the time of risk-reducing BSO?

How do you manage patients with germline BRCA mutations who have STIC lesions found at the time of risk-reducing BSO?

Most experts agree these are worrisome lesions, likely precursors to high-grade serous carcinoma (HGSC). It is also biologically plausible that the presence of serous tubal intraepith...